miR-128 levels are significantly decreased in PCa tissue and serum; low miR-128 is associated with aggressive features (advanced stage, lymph node metastasis, high pre-op PSA, angiolymphatic invasion) and independently predicts shorter biochemical recurrence-free survival. Here, KLK3 is linked to posterior cortical atrophy.